Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On
The Company has six months following receipt of the Notice to regain compliance
with the minimum share price requirement. The Company may regain compliance at
any time during the six-month cure period if on the last trading day of any
calendar month during the six-month cure period the Common Stock has a closing
share price of at least
As required by Section 802.01C, the Company will notify the NYSE within 10 business days of receipt of the Notice that it intends to cure the stock price deficiency and to return to compliance with the NYSE's continued listing standards. The Company is considering all available options to regain compliance with the NYSE's continued listing standards, including through the implementation of the one-for-ten reverse stock split of the Company's Common Stock as further discussed under Item 3.03 of this Current Report on Form 8-K, in order for the Company to seek to increase the closing share price of the Common Stock and regain compliance with the NYSE's continued listing standards. The reverse stock split is, absent other factors, expected to proportionately increase the share price of the Company's Common Stock to a level above the current market trading price, although there is no assurance that this will occur. Additionally, there is no assurance that the reverse stock split will allow the Company to regain compliance with the NYSE's continued listing standards.
Item 3.03 Material Modification to Rights of Security Holders.
In connection with the previously announced one-for-ten reverse stock split (the
"Reverse Stock Split") of shares of Common Stock of the Company, the Company has
filed a Certificate of Amendment (the "Amendment") to its Amended and Restated
Certificate of Incorporation with the Secretary of State of the
The Reverse Stock Split did not change the number of authorized shares under the
Company's Amended and Restated Certificate of Incorporation, which continues to
consist of 250,000,000 shares, of which 50,000,000 shares are designated as
preferred stock and 200,000,000 shares are designated as Common Stock. The
Reverse Stock Split also did not affect the number of shares of issued and
outstanding preferred stock, par value
Pursuant to the Amendment, any fraction of a share of Common Stock that would
otherwise have resulted from the Reverse Stock Split will be settled by cash
payment, calculated according to the closing price per share of the Common Stock
as reported on the NYSE as of
2
--------------------------------------------------------------------------------
The foregoing description of the Amendment is a summary and is qualified in its entirety by the terms of the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
The information under Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference into this Item 5.03.
Item 7.01 Regulation FD Disclosure.
On
On
The information in Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1 and Exhibit 99.2, is being "furnished" pursuant to General Instruction B.2 of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any Company filing, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
This Current Report on Form 8-K contains certain "forward-looking statements." All statements, other than statements of historical facts, included in this Current Report on Form 8-K that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future, are forward-looking statements. These statements are based on certain assumptions made by the Company based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause the Company's actual results to differ materially from those implied or expressed by the forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Item 8.01 Other Events.
Adjustment to Equity Plans and Awards
At the Effective Time, the aggregate number of shares of Common Stock issuable
under the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation ofCharah Solutions, Inc. 99.1* Press release datedDecember 28, 2022 99.2* Press release datedDecember 30, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished herewith. 3
--------------------------------------------------------------------------------
© Edgar Online, source